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RESEARCH NOTE
Evolution of NCoR-1 and NCoR-2 corepressor 
alternative mRNA splicing in placental mammals
Martin L. Privalsky1*  and Michael L. Goodson2
Abstract 
Objective: The NCoR-1 and NCoR-2 corepressors are products of an early gene duplication near the beginning of 
vertebrate evolution and play both overlapping and divergent roles in development and physiology. Alternative-splic-
ing of NCoR-1 and NCoR-2 further customizes their functions. To better understand the evolutionary basis of this phe-
nomenon we extended our prior study of NCoR-1 and NCoR-2 alternative-splicing to an expanded series of species.
Results: Alternative-splicing of NCoR-2 was observed in all vertebrates examined whereas alternative-splicing of 
NCoR-1 was largely limited to placental mammals. Notably the most prominent of the NCoR-1 alternative-splicing 
events specific to the placental lineage, in exon 37 that plays a key role in murine metabolism, mimics in many 
features an analogous alternative-splicing event that appeared in NCoR-2 much earlier at the beginning of the 
vertebrate radiation. Detection of additional alternative-splicing events, at exons 28 in NCoR-1 or NCoR-2, was limited 
to the Rodentia or Primates examined, indicating both corepressor paralogs continued to acquire additional splice 
variations more recently and independently of one another. Our results suggest that the NCoR-1/NCoR-2 paralogs 
have been subject to a mix of shared and distinct selective pressures, resulting in the pattern of divergent and conver-
gent alternative-splicing observed in extant species.
Keywords: Alternative mRNA splicing, Evolution, Corepressors, Transcriptional regulation, Nuclear receptors, Nuclear 
hormone receptors, NCoR, SMRT
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Introduction
The NCoR-1 and NCoR-2 corepressors bind and medi-
ate transcriptional repression by the nuclear receptor 
family of hormone-regulated transcription factors [1–5]. 
NCoR-1 and -2 share ~ 40% sequence identity and a com-
mon molecular architecture [5–7]. Both NCoR-1 and -2 
possess N-terminal Silencing Domains (SDs) that recruit 
additional proteins to form a larger corepressor holo-
complex, and C-terminal Receptor Interaction Domains 
(RIDs) that tether these holocomplexes to their nuclear 
receptor partners on target genes [6, 8–11]. Despite these 
commonalities NCoR-1 and -2 exert unique as well as 
overlapping molecular and biological functions [6, 8].
Whereas NCoR-1 and NCoR-2 are present as two dis-
tinct loci in all the craniate genomes analyzed, NCoR 
sequences in cephalochordates, urochordates, hemichor-
dates, and echinoderms are encoded by a single locus 
[12]. NCoR-1 and -2 are therefore considered the prod-
ucts of gene duplication and divergence events that 
began near the origin of vertebrate evolution. Notably 
both NCoR-1 and -2 in mammals undergo alternative 
mRNA splicing that further broadens the diversity of 
actions available to each paralog and allows these actions 
to be customized for different purposes in different cell 
types [12–23], and in response to different signals [24, 
25]. Understanding the evolution and extant patterns of 
utilization of these alternative-splicing events is impor-
tant for understanding the biological roles of the different 
splice variants and how the functions of the NCoR par-
alogs have been customized to fit the differing require-
ments of different organisms.
We previously reported that whereas NCoR-2 alter-
native-splicing was detected in all the vertebrates exam-
ined, NCoR-1 splicing was apparently restricted to the 
placental mammals, an observation suggesting these two 
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corepressors may have been subject to distinct forms 
of evolution subsequent to their gene duplication [23]. 
However our prior study was limited in scope with only 
3 placental mammals and 5 non-placental vertebrates 
analyzed. To better understand the evolutionary relation-
ships in this phenomenon, we have now expanded our 
analysis of alternative-splicing of NCoR-1 and NCoR-2 
to a significantly wider series of eutherian lineages. Our 
new data help to confirm and elaborate on the concepts 
we proposed in our prior study, as well as providing a 
broader information base for further analysis and study.
Main text
Methods
Alternative-splicing was quantified from RNA pre-
pared from nucleated peripheral blood and assayed 
by a reverse transcriptase PCR quantification method 
employing primers that spanned each alternatively-
spliced site [14, 16, 17, 20, 21, 23, 25]. The primer 
sequences and a detailed description and discussion 
of the sensitivity and accuracy of this method are pro-
vided in Additional file  1. The relative abundance of 
each alternatively-spliced corepressor variant was 
calculated as a percentage of the sum of all the alter-
natively-spliced isoforms produced at that alternative-
splice location. The mean and standard deviation of 3 
or more experiments for each species were determined. 
Data from several species analyzed previously [23] are 
included in Fig.  1 for comparison. NCoR-2 was previ-
ously referred to as SMRT (an alternative nomencla-
ture); the exon numbering system here is as in [23].
Results
Convergent evolution at a nuclear receptor‑specificity 
determinant within NCoR‑1/2 exons 37/40
Alternative mRNA splicing at a receptor specific-
ity determinant (RID-3) within exon 37 of mammalian 
NCoR-1 (mapping to exon 40 in NCoR-2) is known to 
Fig. 1 Schematic of alternative corepressor splicing compared to an evolutionary dendrogram. The abundance of each alternative-splice variant 
from each splice site analyzed is presented schematically as a red bar, with its thickness proportional to the percent of the total splice variants 
expressed from that site (= 100%, see key). Absence of a bar indicates “not detected” (< 2% of total expression at each splice site); see the Limitations 
section and Additional file 1 for an expanded discussion of the sensitivity and accuracy of the RT-PCR technique). The species/sources newly 
analyzed for the current study (Alligator, Alligator mississippiensis; Bat, Eidolon helvum; Cat, Felis silvestris catus; Chicken, Gallus gallus domesticus; 
Dog, Canis lupus familiaris; Elephant, Loxodonta africana; Horse, Equus ferus caballus, Human, Homo sapien; Mouse, Mus musculus; Pig, Sus scrofa 
domesticus; Rabbit, Oryctolagus cuniculus; Rat, Rattus norvegicus; Rhesus, Macaca mulatta) are listed in black text and represent assays of RNA 
populations isolated from peripheral blood. Several additional species analyzed in a prior study [23], in grey text, are presented for comparison 
purposes and represent assays of RNA from non-hematological samples (Sheep, Ovis aries adult liver; Opossum, Monodelphis domestica adult liver; 
Turtle, Trachemys scripta adult liver; Frog, Xenopus laevis stage 45; Zebrafish, Danio rerio stage 84 h). The evolutionary relationships of the species are 
presented as a dendrogram with an estimate of divergence times (in millions of years, Mrys) presented below; please note break in time line. For 
ease of comparisons with other publications our prior nomenclature (NCoR and SMRT [23]) has been changed in the current manuscript to NCoR-1 
and NCoR-2, respectively. The exon numbering system is that employed in our prior study [23]
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have profound effects on the molecular and biological 
properties of these corepressors, including the control 
of lipid and glucose metabolism [13, 16–19]. Our new 
results confirm that although this alternative-splicing 
occurred in NCoR-2 in virtually all the vertebrates exam-
ined, alternative-splicing at this position in NCoR-1 was 
limited within our sensitivity of detection to the placental 
mammals analyzed (Table 1 and Fig. 1). Notably our new 
results also demonstrated that NCoR-1 exon 37 alter-
native-splicing occurred in all the placental mammals 
investigated, including Proboscidea (Table  1 and Fig.  1), 
indicative of a very early evolutionary acquisition of this 
trait within this clade and placing this convergent evo-
lutionary event as arising in NCoR-1 300 to 400 million 
years after the appearance of the comparable alternative-
splicing event in NCoR-2.
Divergent evolution at a nuclear receptor‑specificity 
determinant within NCoR‑2 exon 47
Our current results also documented that alternative-
splicing at a second site important for nuclear receptor-
specificity, within NCoR-2 exon 47 and encompassing/
flanking RID-1 [15], was widely distributed among all the 
vertebrate lineages examined, but in contrast to the exon 
37/40 splice no comparable alternative-splice form was 
detected in the NCoR-1 paralog in any species tested 
(Table 1 and Fig. 1). We interpret this alternative-splicing 
event as a divergent acquisition by the NCoR-2 corepres-
sor early after duplication of the common ancestral gene 
that, unlike exon 37/40 alternative-splicing, retained a par-
alog-restricted role over subsequent evolutionary time.
Alternative‑splicing events at positions likely to influence 
functions of the corepressor other than nuclear receptor 
specificity
Additional alternative-splicing events were observed in 
our analysis at NCoR-1 and NCoR-2 exons 28 that were 
apparently restricted to the Primates and Rodentia exam-
ined and were probably acquired relatively late in placental 
mammalian evolution (Table 1 and Fig. 1). These mapped 
to or near corepressor regions, such as SD sequences, that 
are likely to influence assembly or other functions of the 
corepressor complex rather than nuclear receptor specific-
ity. The precise locations and natures of these alternative-
splice sites are non-identical in NCoR-1 versus NCoR-2, 
consistent with these alternative-spliced also representing 
the products of divergent evolutionary events.
Newly recognized, taxonomically‑restricted 
alternative‑splicing at the C‑terminus of NCoR‑2
The current study also newly detected an alternative-
splice variant of NCoR-1 that deletes all of exon 45 (exon 
45-, Table 1 and Fig. 1), removing portions of a corepres-
sor domain associated with Mitogen-Activated Kinase 
cascade-regulation [24]. This NCoR-1 splice variant was 
not seen in NCoR-2 and was only detected in the two 
Carnivora tested and in an Anura. The latter is notable in 
that it represents the only observed example of any form 
of NCoR-1 alternative-splicing in non-mammals. Our 
failure to previously detect this splice form was a conse-
quence of the unanticipated small size of the correspond-
ing PCR product generated by the primers in our prior 
studies.
Discussion
Both NCoR-1 and -2 are subject to alternative mRNA 
splicing, generating an extensive series of corepressor 
protein variants that are expressed at different abun-
dances in different tissues, preferentially associate with 
different transcription factor partners, respond to sig-
nal transduction pathways in distinct ways, and play 
distinguishable, even opposing, biological roles [13, 
16–20]. This alternative-splicing is a major determi-
nant of NCoR corepressor function that further broad-
ens the diversity of actions available to each paralog and 
allows these actions to be customized for different pur-
poses in different cell types and in response to different 
signals. Understanding and comparing the evolution 
and extant patterns of utilization of these alternative-
splicing events in NCoR-1 versus NCoR-2 should there-
fore provide important insights into the biological roles 
of the different splice variants and how the functions of 
these paralogs have been customized to fit the differing 
requirements of different organisms.
With this goal we report here an expanded analy-
sis of alternative-splicing in NCoR-1 and NCoR-2 to 
more fully understand the origins of this phenomenon. 
Our studies revealed that there are both commonalities 
and substantial differences in the alternative splicing of 
NCoR-1 versus NCoR-2, presumably reflecting and help-
ing to mediate the multiple biological roles of these two 
paralogs.
We previously suggested, based on analysis of a lim-
ited number of species, that NCoR-2 alternative-splic-
ing likely occurs in all vertebrates, whereas NCoR-1 
splicing is restricted to the placental mammals [23]. 
Our current expanded study strengthens that hypoth-
esis (with one exception, see below) and given the very 
early divergence of Afrotheria/Proboscidea during the 
placental mammal radiation, our new data places the 
acquisition of NCoR-1 alternative-splicing as likely hav-
ing occurred during the Cretaceous period some 300 to 
400 million years after the acquisition of alternative-
splicing by NCoR-2. Further, despite its later evolution-
ary appearance, the most prominent and wide spread 
Page 4 of 6Privalsky and Goodson  BMC Res Notes          (2019) 12:343 
Ta
bl
e 
1 
A
lt
er
na
ti
ve
 s
pl
ic
in
g 
of
 N
Co
R-
1 
an
d 
N
Co
R-
2 
co
re
pr
es
so
rs
A
lte
rn
at
iv
e 
m
RN
A
 s
pl
ic
in
g 
w
as
 d
et
er
m
in
ed
 a
s 
de
sc
rib
ed
 in
 "M
et
ho
ds
" a
nd
 A
dd
iti
on
al
 fi
le
 1
 fr
om
 R
N
A
 is
ol
at
ed
 fr
om
 p
er
ip
he
ra
l b
lo
od
 fr
om
 e
ac
h 
sp
ec
ie
s 
lis
te
d 
(A
lli
ga
to
r, 
Al
lig
at
or
 m
is
si
ss
ip
pi
en
si
s; 
Ba
t, 
Ei
do
lo
n 
he
lv
um
; C
at
, 
Fe
lis
 si
lv
es
tr
is
 ca
tu
s; 
Ch
ic
ke
n,
 G
al
lu
s g
al
lu
s d
om
es
tic
us
; D
og
, C
an
is
 lu
pu
s f
am
ili
ar
is
; E
le
ph
an
t, 
Lo
xo
do
nt
a 
af
ric
an
a;
 H
or
se
, E
qu
us
 fe
ru
s c
ab
al
lu
s, 
H
um
an
, H
om
o 
sa
pi
en
; M
ou
se
, M
us
 m
us
cu
lu
s; 
Pi
g,
 S
us
 sc
ro
fa
 d
om
es
tic
us
; R
ab
bi
t, 
O
ry
ct
ol
ag
us
 c
un
ic
ul
us
; R
at
, R
at
tu
s n
or
ve
gi
cu
s; 
Rh
es
us
, M
ac
ac
a 
m
ul
at
ta
). 
Re
su
lts
 fr
om
 a
n 
in
di
vi
du
al
 o
f e
ac
h 
sp
ec
ie
s 
ar
e 
pr
es
en
te
d.
 T
he
 re
la
tiv
e 
ab
un
da
nc
e 
of
 e
ac
h 
al
te
rn
at
iv
e-
sp
lic
e 
va
ria
nt
 fr
om
 e
ac
h 
sp
lic
e 
si
te
 a
na
ly
ze
d 
is
 
pr
es
en
te
d 
as
 a
 p
er
ce
nt
 o
f t
he
 to
ta
l s
pl
ic
e 
va
ria
nt
s 
ex
pr
es
se
d 
fr
om
 th
at
 s
ite
 (s
um
 =
 1
00
%
)
N
D
 =
 n
ot
 d
et
ec
te
d 
(li
m
its
 o
f d
et
ec
tio
n 
w
er
e 
es
tim
at
ed
 a
s <
 2
%
 o
f t
ot
al
 e
xp
re
ss
io
n 
at
 e
ac
h 
sp
lic
e 
si
te
, t
he
 li
m
its
 o
f a
cc
ur
at
e 
qu
an
tit
at
io
n 
as
 >
 5
%
). 
Th
e 
st
ru
ct
ur
es
 o
f t
he
 a
lte
rn
at
iv
e-
sp
lic
ed
 tr
an
sc
rip
ts
 a
re
 d
et
ai
le
d 
in
 [2
3]
 
ex
ce
pt
 fo
r t
he
 N
Co
R-
1 
ex
on
 4
5−
 s
pl
ic
e 
va
ria
nt
, w
hi
ch
 w
as
 n
ew
ly
 re
co
gn
iz
ed
 fr
om
 th
e 
cu
rr
en
t a
na
ly
si
s 
an
d 
w
as
 c
on
fir
m
ed
 b
y 
se
qu
en
ce
 a
na
ly
si
s 
of
 th
e 
PC
R 
pr
od
uc
ts
. T
he
 m
ea
n 
an
d 
(s
ta
nd
ar
d 
er
ro
r)
 o
f 3
 o
r m
or
e 
an
al
yz
es
 
ar
e 
sh
ow
n 
fo
r e
ac
h 
va
lu
e
* 
D
at
a 
no
t a
va
ila
bl
e.
 S
ee
 “L
im
ita
tio
ns
” a
nd
 A
dd
iti
on
al
 fi
le
 1
 fo
r a
n 
ex
pa
nd
ed
 d
is
cu
ss
io
n 
of
 th
e 
se
ns
iti
vi
ty
 a
nd
 a
cc
ur
ac
y 
of
 th
is
 R
T-
PC
R 
m
et
ho
do
lo
gy
Sp
ec
ie
s
N
Co
R-
1
N
Co
R-
2
28
b+
28
b−
37
b+
37
b−
45
a+
45
a−
45
−
28
b+
28
b−
40
b+
40
b−
47
b+
47
b−
47
−
A
lli
ga
to
r
10
0
N
D
10
0
N
D
10
0
N
D
N
D
10
0
N
D
29
.0
 (4
.4
)
71
.0
 (4
.4
)
22
.4
 (5
.3
)
40
.0
 (6
.0
)
37
.6
 (5
.3
)
Ba
t
10
0
N
D
73
.1
 (8
.7
)
26
.9
 (8
.7
)
10
0
N
D
N
D
10
0
N
D
52
.5
 (9
.0
)
47
.5
 (9
.0
)
*
*
*
Ca
t
10
0
N
D
59
.8
 (1
.7
)
40
.2
 (1
.7
)
49
.0
 (2
.3
)
N
D
51
.0
 (2
.3
)
10
0
N
D
25
.1
 (1
.2
)
74
.9
 (1
.2
)
10
0
N
D
N
D
C
hi
ck
en
10
0
N
D
10
0
N
D
10
0
N
D
N
D
10
0
N
D
N
D
10
0
24
.6
 (3
.8
)
41
.8
 (3
.9
)
33
.6
 (3
.6
)
D
og
10
0
N
D
64
.4
 (3
.9
)
35
.6
 (3
.9
)
59
.5
 (2
.2
)
N
D
40
.5
 (2
.2
)
10
0
N
D
21
.7
 (2
.6
)
78
.3
 (2
.6
)
28
.0
 (4
.5
)
72
.0
 (4
.5
)
N
D
El
ep
ha
nt
10
0
N
D
89
.4
 (3
.3
)
10
.6
 (3
.3
)
10
0
N
D
N
D
10
0
N
D
30
.4
 (2
.9
)
69
.6
 (2
.9
)
24
.3
 (3
.1
)
46
.0
 (5
.3
)
29
.7
 (5
.5
)
H
or
se
10
0
N
D
69
.3
 (6
.8
)
30
.7
 (6
.8
)
10
0
N
D
N
D
10
0
N
D
26
.8
 (5
.4
)
73
.2
 (5
.4
)
N
D
46
.4
 (6
.6
)
53
.6
 (6
.6
)
H
um
an
10
0
N
D
70
.2
 (5
.5
)
29
.8
 (5
.5
)
10
0
N
D
N
D
86
.0
 (2
.5
)
14
.0
 (2
.5
)
17
.5
 (3
.9
)
82
.5
 (3
.9
)
20
.4
 (1
.8
)
53
.6
 (1
.5
)
26
.0
 (1
.9
)
M
ou
se
76
.2
 (0
.2
)
23
.8
 (0
.2
)
54
.2
 (2
.4
)
45
.8
 (2
.4
)
88
.8
 (0
.9
)
11
.2
 (0
.9
)
N
D
86
.9
 (2
.7
)
13
.1
 (2
.7
)
32
.9
 (2
.3
)
67
.1
 (2
.3
)
17
.2
 (1
.8
)
61
.2
 (4
.2
)
21
.6
 (2
.8
)
Pi
g
10
0
N
D
55
.0
 (1
.5
)
45
.0
 (1
.5
)
10
0
N
D
N
D
10
0
N
D
27
.9
 (0
.6
)
72
.1
 (0
.6
)
N
D
64
.5
 (1
.7
)
35
.5
 (1
.7
)
Ra
bb
it
10
0
N
D
63
.8
 (1
.3
)
36
.2
 (1
.3
)
10
0
N
D
N
D
10
0
N
D
15
.2
 (1
.1
)
84
.8
 (1
.1
)
N
D
54
.4
 (3
.4
)
45
.6
 (3
.4
)
Ra
t
73
.2
 (1
.7
)
26
.8
 (1
.7
)
58
.0
 (3
.6
)
42
.0
 (3
.6
)
10
0
N
D
N
D
10
0
N
D
32
.8
 (2
.0
)
67
.2
 (2
.0
)
17
.3
 (2
.1
)
60
.3
 (1
.6
)
22
.3
 (3
.1
)
Rh
es
us
10
0
N
D
63
.8
 (5
.4
)
36
.2
 (5
.4
)
10
0
N
D
N
D
69
.7
 (2
.6
)
30
.2
 (2
.6
)
19
.5
 (3
.0
)
80
.5
 (3
.0
)
19
.5
 (2
.1
)
58
.6
 (6
.1
)
22
.0
 (6
.4
)
Page 5 of 6Privalsky and Goodson  BMC Res Notes          (2019) 12:343 
of the alternative-splicing events in mammalian NCoR-
1, at the RID-3 domain in exon 37, mimics in many of 
its structural and molecular features a RID-3/exon 40 
alternative-splicing event acquired by NCoR-2 at the 
beginning of the vertebrate radiation. Alternative-splic-
ing at these sites alters the affinity of the corepressor 
proteins for their nuclear receptor partners, including 
those important in control of lipid and carbohydrate 
metabolism. We speculate that the later acquisition of 
this alternative-splicing event by NCoR-1 in the pla-
cental mammals may reflect a unique role for this core-
pressor variant in energy homeostasis in this lineage.
Additional alternative-splicing events, at NCoR-1 
exon 28 and 45, and at NCoR-2 exon 28 and 47, were 
each unique to their corresponding paralog and appear 
to be divergent evolutionary events. The NCoR-2 exon 
47 alternative-splice site maps to RID-1 and is known 
to alter the affinity of the encoded corepressor protein 
toward a subset of its nuclear receptor partners. In con-
trast the NCoR-1 exon 28 and NCoR-2 exon 28 splicing 
events map not to RIDs but to regions likely to influ-
ence assembly (SD domains) or other functions of the 
corepressor complex. These exon 28 splicing events 
were non-identical in NCoR-1 and NCoR-2 and their 
detection was limited to the Rodentia and Primates 
examined, suggesting that both paralogs continued to 
acquire additional splice variations within the past 90 
to 100 million years and did so independently of one 
another.
Our new analysis also revealed a previously unrecog-
nized alternative-splice event in NCoR-1 exon 45 that 
removed all of exon 45 and was found exclusively in the 
two Carnivora tested and in the amphibian Xenopus. 
The only other alternative-splice event known at this 
exon removes only a portion of exon 45 [exon 45a−] 
and is limited to mice. The basis for this tight species 
restriction is unclear, as are the exact effects of these 
splicing events on NCoR-1 function, although based on 
location they may alter regulation of NCoR function 
by MAP kinase cascade signaling. The presence of the 
exon 45− splice in Xenopus is the first known exam-
ple of NCoR-1 alternative-splicing in a non-mammal. 
Analysis of additional amphibian and related species 
will be required to better understand the taxonomic 
extent, mechanistic origin, and biological implications 
of this unanticipated observation.
In conclusion our results are most consistent with the 
NCoR-1 and NCoR-2 corepressor paralogs having been 
subject to a mix of shared and distinct selective pres-
sures that differed in different lineages, leading to the 
current pattern of divergent and convergent  alterna-
tive-splicing events observed in extant species.
Limitations
This study focuses on alternative-spliced sites within 
NCoR-1 and -2 that were previously recognized and 
in many cases established as having molecular or bio-
logical effects; there may be additional sites of alterna-
tive-splicing in one or more species not queried by the 
primer pairs used here. Ethical and access limitations in 
working with many of the species required the current 
study to be restricted to analysis of peripheral blood 
samples; we cannot fully exclude the possibility that 
a splice variant not detected in peripheral blood may 
nonetheless be expressed by that species in another 
tissue. Nonetheless our prior studies on model organ-
isms suggest that the detected presence or absence of 
a given variant in peripheral blood is largely predictive 
of its detected presence or absence in other tissues in 
that organism (e.g. [23]). Similarly although our meth-
odology can detect alternative-splice products at levels 
down to ~ 2% of total we cannot exclude certain splice 
variants were not observed because they are expressed 
at levels even below this limit; such very low levels of 
expression, if they exist, would be of unclear biological 
significance.
Due to practical and ethical limitations it was typi-
cally not possible to obtain samples from multiple indi-
viduals from within a given (exotic) species; however 
our analysis of model organisms such as human and 
mice demonstrated relatively little variation in alter-
native-splicing from individual to individual (e.g. [14, 
16, 17, 20, 23, 25] and data not shown), indicating that 
this restriction was unlikely to substantially alter the 
interpretation of the data presented here. Finally our 
methodology required access to freshly drawn periph-
eral blood and sufficient species-specific sequence 
information to design appropriate PCR primers. These 
dual requirements restricted our ability to expand our 
analysis to taxonomies not reported here or to include 
additional representatives within the lineages that were 
studied. Nonetheless the patterns of alternative mRNA 
splicing were generally very similar in the cases where 
we were able to compare two species within a shared 
lineage.
Additional file
Additional file 1. Expanded methods. This file details the RT-PCR meth-
odology, the oligonucleotide primers employed, and the issues relating to 
the quantitation and sensitivity of the data.
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